192 related articles for article (PubMed ID: 17411415)
1. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415
[TBL] [Abstract][Full Text] [Related]
2. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
3. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
[TBL] [Abstract][Full Text] [Related]
4. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Hartel DM; Schoenbaum EE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
[TBL] [Abstract][Full Text] [Related]
5. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
[TBL] [Abstract][Full Text] [Related]
6. Methadone maintenance therapy outcomes in Iran.
Noori R; Narenjiha H; Aghabakhshi H; Habibi G; Khoshkrood Mansoori B
Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
[TBL] [Abstract][Full Text] [Related]
7. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
Avants SK; Margolin A; Usubiaga MH; Doebrick C
J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
[TBL] [Abstract][Full Text] [Related]
8. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.
Battjes RJ; Pickens RW; Brown LS
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):90-6. PubMed ID: 7648291
[TBL] [Abstract][Full Text] [Related]
9. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
10. Impact of methadone on drug use and risky sex in China.
Qian HZ; Hao C; Ruan Y; Cassell HM; Chen K; Qin G; Yin L; Schumacher JE; Liang S; Shao Y
J Subst Abuse Treat; 2008 Jun; 34(4):391-7. PubMed ID: 17869049
[TBL] [Abstract][Full Text] [Related]
11. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
Grella CE; Campos M; Anglin MD
AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
[TBL] [Abstract][Full Text] [Related]
12. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
Larance B; Degenhardt L; Copeland J; Dillon P
Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
[TBL] [Abstract][Full Text] [Related]
13. Social context of needle selling in Baltimore, Maryland.
Latkin CA; Davey MA; Hua W
Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
[TBL] [Abstract][Full Text] [Related]
14. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
Serpelloni G; Carrieri MP; Rezza G; Morganti S; Gomma M; Binkin N
AIDS Care; 1994; 6(2):215-20. PubMed ID: 8061081
[TBL] [Abstract][Full Text] [Related]
15. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
Williams AB; McNelly EA; Williams AE; D'Aquila RT
AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
[TBL] [Abstract][Full Text] [Related]
16. The association between acculturation and needle sharing among Puerto Rican injection drug users.
Delgado M; Lundgren LM; Deshpande A; Lonsdale J; Purington T
Eval Program Plann; 2008 Feb; 31(1):83-91. PubMed ID: 17706285
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
[TBL] [Abstract][Full Text] [Related]
18. Reducing the risk of HIV infection associated with illicit drug use.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2006 Feb; 117(2):566-71. PubMed ID: 16452382
[TBL] [Abstract][Full Text] [Related]
19. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
20. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
Judson G; Bird R; O'Connor P; Bevin T; Loan R; Schroder M; McGrath R; Weatherall M; Moriarty H; Robinson G
Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
